ADVERTISEMENT
ADVERTISEMENT
Black and white world map, with lines connecting red areas that indicate COVID-19 hotspots, along with overlaid drawings of SARS-CoV-2.
WHO Updates the Nomenclature of SARS-CoV-2 Variants
Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.
WHO Updates the Nomenclature of SARS-CoV-2 Variants
WHO Updates the Nomenclature of SARS-CoV-2 Variants

Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.

Rather than being described by the location of where they emerged or an alphanumeric code, variants will be given a Greek letter.

b.1.1.7
Woman holding a CDC COVID-19 vaccination card with both hands.
COVID-19 mRNA Vaccines Appear Effective Against Multiple Variants
Lisa Winter | May 6, 2021 | 2 min read
Data from three studies indicate that fully vaccinated patients are able to stave off severe disease from the B.1.1.7, B.1.351, and P.1 variants.
COVID-19, SARS-CoV-2, pandemic, research, reverse genetics, toolkit, antibodies, RNA
Q&A: A Molecular Toolkit to Build SARS-CoV-2 Research Capacity
Asher Jones | Mar 3, 2021 | 6 min read
Sam Wilson discusses a user-friendly set of resources that he and his collaborators developed to aid labs pivoting to study COVID-19.
COVID-19, SARS-CoV-2, coronavirus, pandemic, virus, B.1.1.7, B.1.525, variant, UK
Another Potentially Immunity-Evading SARS-CoV-2 Variant Detected
Asher Jones | Feb 16, 2021 | 2 min read
B.1.525 shares a mutation with the B.1.351 variant first detected in South Africa that seems to allow the virus to dodge the immune system.
SARS-CoV-2 with Genomic Deletions Escapes an Antibody
Abby Olena, PhD | Feb 16, 2021 | 4 min read
Researchers identify deletions in the N-terminal domain of the spike protein that allow the coronavirus to avoid antibody neutralization and that may contribute to the emergence of new variants.
nextstrain sars-cov-2 variant tracking covid-19 coronavirus pandemic n510y 501Y.V2 b.1.1.7 B.1.351 e484k k417n p.1 virology
Side-by-Side Comparisons of Important SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021 | 3 min read
Here’s our brief guide to the most noteworthy mutations in the novel coronavirus.
Special report
501Y.V2 b.1.1.7 B.1.351 coronavirus COVID-19 e484k epidemiology genetics & genomics k417n micro n501y news feature p.1 pandemic SARS-CoV-2 virology variants
A Guide to Emerging SARS-CoV-2 Variants
Katarina Zimmer | Jan 26, 2021 | 10 min read
Scientists across the world are closely tracking the spread of mutations in the coronavirus and investigating whether they could render current vaccines less effective.
COVID-19, SARS-CoV-2, pandemic, B.1.1.7, 501Y.V2, B.1.351, vaccine, immunity, virus, coronavirus, Moderna, South Africa, variant
Moderna Developing Booster Shot for New Virus Variant B.1.351
Asher Jones | Jan 25, 2021 | 2 min read
New data suggest that the company’s approved COVID-19 vaccine protects against different virus variants, but could be less effective against the one that originated in South Africa.
a sign reading "Please keep your distance"
Data Hint B.1.1.7 Could Be More Deadly Than Thought
Shawna Williams | Jan 25, 2021 | 2 min read
In addition to being more transmissible, the variant now dominant in the UK may be about 30 percent more deadly than previous strains, but much uncertainty remains.
sars-cov-2 coronavirus covid-19 pandemic 501.v2 b.1.1.7 variant mutation spike protein pfizer biontech vaccine serum antibody
Mutation in SARS-CoV-2 Variant Does Not Affect Vaccine: Study
Kerry Grens | Jan 8, 2021 | 2 min read
An engineered coronavirus with the N501Y mutation—one of many mutations present in the emerging B.1.1.7 and 501.V2 variants of the coronavirus—is neutralized by the sera of COVID-19 vaccine recipients.
ADVERTISEMENT